drugset / Trial / NCT00252174

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

NCT00252174

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a pilot study intended to find out if 3,4-methylenedioxymethamphetamine (MDMA) is safe and can help people with advanced stage cancer and anxiety arising from the cancer diagnosis.

Timeline

Start
2007-02
Primary completion
2010-12
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Midomafetamine Unknown 25 mg
Subject Midomafetamine Unknown 125 mg

Indications